Smith & Nephew PLC

SN.: XLON (GBR)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|%#LOCK|J?n#xLOCK|q^Qt%MN

Smith & Nephew Earnings: Lackluster Knee Growth Offset by Hips and Sports Medicine

Smith & Nephew's third-quarter performance included year-over-year revenue growth in the orthopedics and sports medicine segments of 4% and 5%, respectively, on an underlying basis.

Sponsor Center